HALDRONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Haldrone, and when can generic versions of Haldrone launch?
Haldrone is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in HALDRONE is paramethasone acetate. There are two drug master file entries for this compound. Additional details are available on the paramethasone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HALDRONE?
- What are the global sales for HALDRONE?
- What is Average Wholesale Price for HALDRONE?
Summary for HALDRONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Patent Applications: | 2,555 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HALDRONE at DailyMed |
![HALDRONE drug patent expirations Drug patent expirations by year for HALDRONE](/p/graph/s/t/HALDRONE-patent-expirations.png)
US Patents and Regulatory Information for HALDRONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | HALDRONE | paramethasone acetate | TABLET;ORAL | 012772-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | HALDRONE | paramethasone acetate | TABLET;ORAL | 012772-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HALDRONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lilly | HALDRONE | paramethasone acetate | TABLET;ORAL | 012772-005 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Lilly | HALDRONE | paramethasone acetate | TABLET;ORAL | 012772-006 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for HALDRONE
See the table below for patents covering HALDRONE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
United Kingdom | 902293 | ⤷ Sign Up | |
Switzerland | 378881 | Verfahren zur Herstellung von Steroidverbindungen | ⤷ Sign Up |
United Kingdom | 902292 | ⤷ Sign Up | |
United Kingdom | 902294 | ⤷ Sign Up | |
Germany | 1239307 | Verfahren zur Herstellung therapeutisch wirksamer Steroidverbindungen | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |